CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 79% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
US English
2.6422
3.65%
Market Trading Hours* (UTC) Open now
Closes on Wednesday at 21:00

Mon - Fri: 14:30 - 21:00

  • Summary
  • Historical Data
  • Events
  • Income Statement
  • Balance Sheet
  • Cash Flow
  • Ownership
Trading Conditions
Spread 0.0256
Long position overnight fee

Long position overnight fee


Margin. Your investment $1,000.00
Overnight fee -0.026346 %
Charges from full value of position ($-5.01)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
-0.026346%
Short position overnight fee

Short position overnight fee


Margin. Your investment $1,000.00
Overnight fee 0.004124 %
Charges from full value of position ($0.78)
Trade size with leverage ~ $20,000.00
Money from leverage ~ $19,000.00

Go to platform
0.004124%
Overnight fee time 22:00 (UTC)
Min traded quantity 1
Currency USD
Margin 5%
Stock exchange United States of America
Commission on trade 0%

*Information provided by Capital.com

Accuray Inc ESG Risk Ratings

High Medium Low Negligible

‘C’ score indicates satisfactory relative ESG performance and moderate degree of transparency in reporting material ESG data publicly.

More ESG coverage

Key Stats
Prev. Close* 2.7422
Open* 2.7622
1-Year Change* 36.29%
Day's Range* 2.6322 - 2.7822
52 wk Range 1.85-4.30
Average Volume (10 days) 499.73K
Average Volume (3 months) 8.31M
Market Cap 262.10M
P/E Ratio -100.00K
Shares Outstanding 97.07M
Revenue 455.00M
EPS -0.07
Dividend (Yield %) N/A
Beta 1.57
Next Earnings Date Jan 30, 2024

All data is provided by Refinitiv, except for data marked with an asterisk, which is *data provided by Capital.com

  • Last Week
  • Last Month
  • Last Year
  • Last two Years
  • Max
  • Daily
  • Weekly
  • Monthly
Date Close Change Change (%) Open High Low
Dec 5, 2023 2.7422 0.1700 6.61% 2.5722 2.7522 2.5722
Dec 4, 2023 2.6222 0.1300 5.22% 2.4922 2.6322 2.4822
Dec 1, 2023 2.5222 0.0500 2.02% 2.4722 2.5522 2.3822
Nov 30, 2023 2.5922 -0.0700 -2.63% 2.6622 2.6922 2.5922
Nov 29, 2023 2.6522 0.0200 0.76% 2.6322 2.7222 2.6322
Nov 28, 2023 2.6422 -0.0300 -1.12% 2.6722 2.6822 2.6122
Nov 27, 2023 2.6922 0.0200 0.75% 2.6722 2.7622 2.6722
Nov 24, 2023 2.7722 0.1700 6.53% 2.6022 2.8122 2.6022
Nov 22, 2023 2.7422 0.1300 4.98% 2.6122 2.7522 2.6122
Nov 21, 2023 2.6922 0.0400 1.51% 2.6522 2.7422 2.6522
Nov 20, 2023 2.7022 0.1400 5.46% 2.5622 2.7722 2.5622
Nov 17, 2023 2.5622 0.0400 1.59% 2.5222 2.5622 2.5022
Nov 16, 2023 2.5122 0.0300 1.21% 2.4822 2.5822 2.4422
Nov 15, 2023 2.5322 -0.0400 -1.56% 2.5722 2.7122 2.5222
Nov 14, 2023 2.6622 0.1200 4.72% 2.5422 2.6622 2.5422
Nov 13, 2023 2.5422 0.1000 4.09% 2.4422 2.5522 2.4422
Nov 10, 2023 2.4622 0.0600 2.50% 2.4022 2.4822 2.3822
Nov 9, 2023 2.4322 -0.1800 -6.89% 2.6122 2.6522 2.4322
Nov 8, 2023 2.6522 -0.0700 -2.57% 2.7222 2.8722 2.6522
Nov 7, 2023 2.7222 0.0800 3.03% 2.6422 2.7222 2.6022

Accuray Events

Time (UTC) Country Event
Tuesday, January 30, 2024

Time (UTC)

10:59

Country

US

Event

Q2 2024 Accuray Inc Earnings Release
Q2 2024 Accuray Inc Earnings Release

Forecast

-

Previous

-
Wednesday, April 24, 2024

Time (UTC)

10:59

Country

US

Event

Q3 2024 Accuray Inc Earnings Release
Q3 2024 Accuray Inc Earnings Release

Forecast

-

Previous

-
View all events
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total revenue 447.605 429.909 396.289 382.928 418.785
Revenue 447.605 429.909 396.289 382.928 418.785
Cost of Revenue, Total 293.645 269.954 236.782 233.207 256.134
Gross Profit 153.96 159.955 159.507 149.721 162.651
Total Operating Expense 445.223 421.761 384.002 370.389 418.202
Selling/General/Admin. Expenses, Total 94.449 94.055 84.543 87.398 105.575
Research & Development 57.129 57.752 52.729 49.784 56.493
Operating Income 2.382 8.148 12.287 12.539 0.583
Interest Income (Expense), Net Non-Operating -8.938 -10.506 -17.974 -7.608 -15.749
Net Income Before Taxes -6.788 -2.002 -4.559 5.69 -14.344
Net Income After Taxes -9.28 -5.347 -6.311 3.827 -16.43
Net Income Before Extra. Items -9.28 -5.347 -6.311 3.827 -16.43
Total Extraordinary Items 0 0 0
Net Income -9.28 -5.347 -6.311 3.827 -16.43
Income Available to Common Excl. Extra. Items -9.28 -5.347 -6.311 3.827 -16.43
Income Available to Common Incl. Extra. Items -9.28 -5.347 -6.311 3.827 -16.43
Diluted Net Income -9.28 -5.347 -6.311 3.827 -16.43
Diluted Weighted Average Shares 94.884 92.095 92.031 90.623 87.465
Diluted EPS Excluding Extraordinary Items -0.0978 -0.05806 -0.06857 0.04223 -0.18785
Dividends per Share - Common Stock Primary Issue
Diluted Normalized EPS -0.07931 -0.05806 0.00169 0.04223 -0.18785
Other, Net -0.232 0.356 1.128 0.759 0.822
Unusual Expense (Income) 9.948
Jun 2023 Mar 2023 Dec 2022 Sep 2022 Jun 2022
Total revenue 118.292 118.06 114.76 96.493 110.023
Revenue 118.292 118.06 114.76 96.493 110.023
Cost of Revenue, Total 80.614 79.342 71.793 61.896 67.003
Gross Profit 37.678 38.718 42.967 34.597 43.02
Total Operating Expense 118.749 115.744 112.055 98.675 107.975
Selling/General/Admin. Expenses, Total 23.948 22.193 25.621 22.687 26.403
Research & Development 14.187 14.209 14.641 14.092 14.569
Operating Income -0.457 2.316 2.705 -2.182 2.048
Interest Income (Expense), Net Non-Operating -1.74 -0.941 -3.376 -2.881 -4.918
Other, Net 0.221 -0.254 -0.154 -0.045 1.445
Net Income Before Taxes -1.976 1.121 -0.825 -5.108 -1.425
Net Income After Taxes -2.556 0.599 -1.874 -5.449 -3.452
Net Income Before Extra. Items -2.556 0.599 -1.874 -5.449 -3.452
Net Income -2.556 0.599 -1.874 -5.449 -3.452
Income Available to Common Excl. Extra. Items -2.556 0.599 -1.874 -5.449 -3.452
Income Available to Common Incl. Extra. Items -2.556 0.599 -1.874 -5.449 -3.452
Diluted Net Income -2.556 0.599 -1.874 -5.449 -3.452
Diluted Weighted Average Shares 95.94 97.455 94.567 93.529 93.04
Diluted EPS Excluding Extraordinary Items -0.02664 0.00615 -0.01982 -0.05826 -0.0371
Dividends per Share - Common Stock Primary Issue 0 0 0
Diluted Normalized EPS -0.02664 0.01053 -0.00676 -0.05826 -0.0371
Unusual Expense (Income)
  • Annual
  • Quarterly
2023 2022 2021 2020 2019
Total Current Assets 338.033 350.89 352.773 357.486 344.075
Cash and Short Term Investments 89.402 88.737 116.369 107.577 76.798
Cash
Cash & Equivalents 89.402 88.737 116.369 107.577 76.798
Short Term Investments
Total Receivables, Net 74.777 94.442 85.36 90.599 111.885
Accounts Receivable - Trade, Net 74.777 94.442 85.36 90.599 111.885
Total Inventory 145.15 142.254 125.929 134.374 120.823
Prepaid Expenses 27.612 23.794 21.547 21.227 24.205
Other Current Assets, Total 1.092 1.663 3.568 3.709 10.364
Total Assets 479.214 472.849 480.098 490.927 438.181
Property/Plant/Equipment, Total - Net 46.779 29.483 34.854 43.996 17.122
Property/Plant/Equipment, Total - Gross 125.342 108.693 113.029 128.769 98.018
Accumulated Depreciation, Total -78.563 -79.21 -78.175 -84.773 -80.896
Goodwill, Net 57.681 57.84 57.96 57.717 57.77
Intangibles, Net 0.21 0.25 0.435 0.663 0.679
Note Receivable - Long Term 4.734 5.301 8.1 4.3
Other Long Term Assets, Total 16.649 15.206 18.141 9.036 14.235
Total Current Liabilities 198.637 208.858 192.359 182.271 192.181
Accounts Payable 33.739 31.337 19.467 23.126 29.562
Accrued Expenses 66.215 68.293 62.505 53.367 63.892
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 5.721 8.563 3.79
Other Current Liabilities, Total 92.962 100.665 106.597 105.778 98.727
Total Liabilities 425.555 419.66 411.258 427.292 388.31
Total Long Term Debt 171.562 171.907 170.007 189.307 159.844
Long Term Debt 171.562 171.907 170.007 189.307 159.844
Other Liabilities, Total 55.356 38.895 48.892 55.714 36.285
Total Equity 53.659 53.189 68.84 63.635 49.871
Common Stock 0.097 0.094 0.091 0.091 0.089
Additional Paid-In Capital 555.276 543.211 554.68 545.741 535.332
Retained Earnings (Accumulated Deficit) -502.136 -492.522 -488.024 -481.713 -485.54
Unrealized Gain (Loss) 0
Other Equity, Total 0.422 2.406 2.093 -0.484 -0.01
Total Liabilities & Shareholders’ Equity 479.214 472.849 480.098 490.927 438.181
Total Common Shares Outstanding 96.5346 93.4995 90.8217 91.1781 88.5215
Long Term Investments 15.128 13.879 15.935 13.929
Sep 2023 Jun 2023 Mar 2023 Dec 2022 Sep 2022
Total Current Assets 334.147 338.033 342.915 336.948 335.265
Cash and Short Term Investments 76.918 89.402 89.057 67.729 81.007
Cash & Equivalents 76.918 89.402 89.057 67.729 81.007
Total Receivables, Net 77.37 74.777 77.35 89.187 77.029
Accounts Receivable - Trade, Net 77.37 74.777 77.35 89.187 77.029
Total Inventory 149.977 145.15 150.581 155.665 152.624
Prepaid Expenses 28.798 27.612 25.455 23.536 24.241
Other Current Assets, Total 1.084 1.092 0.472 0.831 0.364
Total Assets 476.83 479.214 475.72 468.769 466.349
Property/Plant/Equipment, Total - Net 49.341 46.779 36.13 36.489 37.727
Property/Plant/Equipment, Total - Gross 128.765 125.342 115.762 117.275 116.831
Accumulated Depreciation, Total -79.424 -78.563 -79.632 -80.786 -79.104
Goodwill, Net 57.656 57.681 57.807 57.776 57.658
Intangibles, Net 0.163 0.21 0.257 0.268 0.214
Long Term Investments 13.121 15.128 12.217 12.276 12.776
Note Receivable - Long Term 5.052 4.734 4.782 5.387
Other Long Term Assets, Total 17.35 16.649 21.612 19.625 22.709
Total Current Liabilities 201.449 198.637 191.829 184.72 192.536
Accounts Payable 34.877 33.739 28.647 33.861 32.945
Accrued Expenses 69.207 66.215 62.254 55.313 65.955
Notes Payable/Short Term Debt 0 0 0 0 0
Current Port. of LT Debt/Capital Leases 6.229 5.721 5.713 5.702 5.705
Other Current Liabilities, Total 91.136 92.962 95.215 89.844 87.931
Total Liabilities 425.886 425.555 421.015 417.024 419.358
Total Long Term Debt 169.792 171.562 172.832 174.102 170.62
Long Term Debt 169.792 171.562 172.832 174.102 170.62
Other Liabilities, Total 54.645 55.356 56.354 58.202 56.202
Total Equity 50.944 53.659 54.705 51.745 46.991
Common Stock 0.097 0.097 0.096 0.095 0.094
Additional Paid-In Capital 557.668 555.276 551.847 550.288 546.117
Retained Earnings (Accumulated Deficit) -505.105 -502.136 -499.58 -500.179 -497.971
Other Equity, Total -1.716 0.422 2.342 1.541 -1.249
Total Liabilities & Shareholders’ Equity 476.83 479.214 475.72 468.769 466.349
Total Common Shares Outstanding 96.7268 96.5346 95.5579 95.4947 93.7788
  • Annual
  • Quarterly
2022 2021 2020 2019 2018
Net income/Starting Line -5.347 -6.311 3.827 -16.43 -23.899
Cash From Operating Activities -2.4 38.512 -1.469 -29.641 18.331
Cash From Operating Activities 5.513 6.389 7.541 10.491 9.732
Non-Cash Items 18.248 30.749 8.69 23.102 22.424
Cash Taxes Paid 1.398 1.873 2.806 2.191 1.46
Cash Interest Paid 7.462 11.892 12.332 9.761 9.187
Changes in Working Capital -22.599 7.799 -21.527 -46.718 10.044
Cash From Investing Activities -4.717 -2.399 -3.728 -4.311 17.766
Capital Expenditures -4.717 -2.32 -3.728 -4.311 -6.609
Other Investing Cash Flow Items, Total 0 -0.079 24.375
Cash From Financing Activities -15.369 -28.805 26.696 28.473 -27.453
Financing Cash Flow Items -0.258 -0.343 -0.207 -0.293
Issuance (Retirement) of Stock, Net 3.889 -11.05 2.45 3.927 4.389
Issuance (Retirement) of Debt, Net -19 -17.412 24.453 24.546 -31.549
Foreign Exchange Effects -5.561 0.982 0.234 0.124 -0.346
Net Change in Cash -28.047 8.29 21.733 -5.355 8.298
Deferred Taxes 1.785 -0.114 -0.086 0.03
Mar 2023 Dec 2022 Sep 2022 Jun 2022 Mar 2022
Net income/Starting Line -6.724 -7.323 -5.449 -5.347 -1.895
Cash From Operating Activities 6.658 -17.968 0.046 -2.4 2.244
Cash From Operating Activities 3.43 2.327 1.176 5.513 4.244
Non-Cash Items 10.872 8.612 4.29 18.248 14.385
Changes in Working Capital -0.92 -21.584 0.029 -22.599 -14.49
Cash From Investing Activities -4.705 -2.806 -1.272 -4.717 -3.321
Capital Expenditures -4.705 -2.806 -1.272 -4.717 -3.321
Other Investing Cash Flow Items, Total 0 0
Cash From Financing Activities -1.59 -0.09 -4.365 -15.369 -15.51
Financing Cash Flow Items -0.364 -0.364 -0.258 -0.258
Issuance (Retirement) of Stock, Net 1.139 1.139 3.889 2.748
Issuance (Retirement) of Debt, Net -2.365 -0.865 -4.365 -19 -18
Foreign Exchange Effects 0.333 -0.079 -2.173 -5.561 -2.326
Net Change in Cash 0.696 -20.943 -7.764 -28.047 -18.913
Deferred Taxes 1.785
Investor Name Investor Type Percent Outstanding Shares Held Shares change Holdings Date Turnover Rating
BlackRock Institutional Trust Company, N.A. Investment Advisor 6.5635 6339670 3928901 2023-06-30 LOW
Archon Capital Management LLC Hedge Fund 6.3203 6104738 0 2023-06-30 MED
Neuberger Berman, LLC Investment Advisor/Hedge Fund 5.6862 5492292 40443 2023-06-30 LOW
The Vanguard Group, Inc. Investment Advisor/Hedge Fund 5.3533 5170802 589717 2023-06-30 LOW
Renaissance Technologies LLC Hedge Fund 3.0374 2933784 28500 2023-06-30 HIGH
Royce Investment Partners Investment Advisor/Hedge Fund 2.9963 2894135 -105000 2023-06-30 LOW
D. E. Shaw & Co., L.P. Hedge Fund 2.8235 2727246 124017 2023-06-30 MED
Wellington Management Company, LLP Investment Advisor/Hedge Fund 2.7938 2698579 -269300 2023-06-30 LOW
Heartland Advisors, Inc. Investment Advisor/Hedge Fund 2.7609 2666750 25000 2023-06-30
Harbert Fund Advisors, Inc Investment Advisor/Hedge Fund 1.9145 1849184 0 2023-06-30 HIGH
Geode Capital Management, L.L.C. Investment Advisor/Hedge Fund 1.8851 1820803 891096 2023-06-30 LOW
State Street Global Advisors (US) Investment Advisor/Hedge Fund 1.8826 1818360 1452894 2023-06-30 LOW
Dimensional Fund Advisors, L.P. Investment Advisor/Hedge Fund 1.7158 1657246 276240 2023-06-30 LOW
Foundry Partners, LLC Investment Advisor 1.5515 1498600 -238827 2023-06-30 MED
Two Sigma Investments, LP Hedge Fund 1.3295 1284147 256381 2023-06-30 HIGH
Dafna Capital Management, LLC Hedge Fund 1.2655 1222358 0 2023-06-30 LOW
Acadian Asset Management LLC Investment Advisor/Hedge Fund 1.1938 1153120 -64054 2023-06-30 MED
Kovack Advisors Inc Investment Advisor 1.1703 1130350 -22700 2023-09-30 LOW
North Star Investment Management Corporation Investment Advisor/Hedge Fund 0.9585 925845 13375 2023-06-30 LOW
BlackRock Financial Management, Inc. Investment Advisor/Hedge Fund 0.9558 923229 179473 2023-06-30 LOW

Trading calculator

Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).

Trade commission
0
  • 1:1
Leverage
1:1
  • 20
  • 100
  • 500
  • 1000
  • 10000
Investment
Trade size (Leverage x Investement):
Open

Close

Short Long

For the avoidance of doubt, this calculation does not include the costs of holding a position overnight (for which there will be additional charges)

Accuray Company profile

About Accuray Incorporated

Accuray Incorporated is a radiation therapy company. The Company develops, manufactures, sells and supports market-changing solutions that are designed to deliver radiation treatments. The Company's technologies include the CyberKnife and TomoTherapy platforms, including the Radixact System. The CyberKnife and TomoTherapy platform, which are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT) and adaptive radiation therapy (ART). The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Financial summary

BRIEF: For the six months ended 31 December 2021, Accuray Incorporated revenues increased 22% to $223.7M. Net loss totaled $849K vs. income of $5.2M. Revenues reflect Product segment increase of 55% to $113.5M, Service segment increase of less than 1% to $110.2M, China (Country) segment increase of 98% to $49.2M, Americas segment increase of 37% to $75M. Net loss reflects Research and development increase of 21% to $28.4M (expense).

Equity composition

Common Stock, $.001 Par, 12/10, 100M auth., 61,865,443 issd., less 2,140,018 shs. in Treas. @ Cost. Insiders own 2.14%. IPO: 2/07, 16M shs. @ $18 per share by JPMorgan, UBS Investment Bank, Piper Jaffray, Jefferies & Co.

Industry: Advanced Medical Equipment & Technology (NEC)

1240 Deming Way
MADISON
WISCONSIN 53717
US

Income Statement

  • Annual
  • Quarterly

News

December RBA preview: no move expected at the final meeting of 2023

The RBA meets on Tuesday, 5th of December, 2023, at 2.30 PM (AEDT). We preview what to expect from this month’s decision.

14:47, 4 December 2023

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

CPI drops more than expected in Europe, Spain’s IBEX 35 looking to break pre-COVID highs

12:39, 30 November 2023

Euro Zone CPI expected to continue dropping; economists warn about cutting too soon

EZ PI expected to drop further but speed of decline

08:16, 29 November 2023

A weaker Dollar drives gold higher

Gold prices have returned above $US2000 per ounce. We run through the factors driving gold and the commodity’s key technicals.

13:49, 28 November 2023

Q3 US Earnings Recap: Profits surprise to the upside, but outlook remains uncertain

US earnings for the third quarter were far better than expected. However, uncertainty about the outlook for company profits continues. We review the quarterly earnings and look ahead to what the markets expect from S&P 500 companies going forward.

13:20, 28 November 2023

RBNZ Preview: Rates expected to remain unchanged at final meeting of 2023

The RBNZ meets for the final time this year on Wednesday, 29th of November, 2023. We preview what to expect and how it could impact the New Zealand Dollar.

13:04, 28 November 2023

Crude prices slide on OPEC+ uncertainty

Crude prices have chopped sideways amid signs of turmoil within OPEC+. We look at the fundamentals of the oil market and the technical levels of WTI.

12:55, 28 November 2023

People also watch

XRP/USD

0.64 Price
+1.460% 1D Chg, %
Long position overnight fee -0.0753%
Short position overnight fee 0.0069%
Overnight fee time 22:00 (UTC)
Spread 0.01168

US100

15,856.20 Price
-0.080% 1D Chg, %
Long position overnight fee -0.0263%
Short position overnight fee 0.0041%
Overnight fee time 22:00 (UTC)
Spread 1.8

BTC/USD

44,119.40 Price
+0.200% 1D Chg, %
Long position overnight fee -0.0616%
Short position overnight fee 0.0137%
Overnight fee time 22:00 (UTC)
Spread 106.00

Gold

2,030.07 Price
+0.480% 1D Chg, %
Long position overnight fee -0.0196%
Short position overnight fee 0.0114%
Overnight fee time 22:00 (UTC)
Spread 0.30

Still looking for a broker you can trust?

Join the 570.000+ traders worldwide that chose to trade with Capital.com

1. Create & verify your account 2. Make your first deposit 3. You’re all set. Start trading